Home > Healthcare > Medical Devices > Diagnostic Devices > In-vitro Toxicology Testing Market

In-vitro Toxicology Testing Market Trends

Report ID: GMI5543
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

In-vitro Toxicology Testing Market Trends

Regulatory agencies are becoming more accepting of in-vitro testing methods. Guidelines and initiatives, such as the Tox21 program, are encouraging the use of alternative methods, contributing to greater regulatory acceptance of in-vitro toxicology data in safety assessments.

The Tox21 (Toxicology in the 21st Century) program is a collaborative effort involving multiple U.S. federal agencies, including the National Institutes of Health (NIH), the U.S. Environmental Protection Agency (EPA), and the U.S. Food and Drug Administration (FDA). Launched in 2008, Tox21 aims to improve the efficiency of toxicity testing by promoting the use of in-vitro methods and computational approaches.
Tox21 focuses on advancing toxicology testing methods to better assess the safety of chemicals and drugs. The program aims to develop alternative testing strategies that are more predictive of human responses, reduce the need for animal testing, and provide quicker and more cost-effective results.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

In-vitro toxicology testing industry reached USD 1.9 billion in revenue in 2023 and is projected to surpass USD 3.6 billion by 2032 attributed to increasing incorporation in drug development and product safety assessment processes by pharmaceutical and cosmetics companies.

The cell culture technology segment is poised for significant growth at 7.8% CAGR during 2024-2032 attributed to the increasing use of organoids, which are three-dimensional, miniature organs grown in vitro.

North America in-vitro toxicology testing market generated USD 857.2 million in revenue in 2023 and is set to exhibit robust growth through 2032 driven by the notable trend toward the increased adoption of in-vitro testing methods as an alternative to traditional animal testing.

Some of the top firms engaged in the in-vitro toxicology testing industry are Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Catalent, Inc., Danaher Corporation, Eurofins Scientific, Evotec S.E., Laboratory Corporation of America Holdings, Merck KGaA, Quest Diagnostics Incorporated, and Thermo Fisher Scientific Inc., among others.